Literature DB >> 27725209

Enhancing heterologous protein expression and secretion in HEK293 cells by means of combination of CMV promoter and IFNα2 signal peptide.

Ramón Román1, Joan Miret2, Federica Scalia3, Antoni Casablancas2, Martí Lecina2, Jordi J Cairó2.   

Abstract

Efficient production and secretion of recombinant proteins in mammalian cell lines relies in a combination of genetic, metabolic and culture strategy factors. The present work assesses the influence of two key genetic components of expression vectors (promoter and signal peptide) on protein production and secretion effciency in HEK293 cells expressing eGFP as a reporter protein. Firstly, the strength of 3 different promoters was evaluated using transient expression methods. Flow cytometry analysis revealed that the highest level of intracellular protein expression was found when eGFP was under the control of CMV promoter, being 3-times higher in comparison to the rest of the promoters tested. Secondly, 5 different signal peptides were assessed in stable transfected cell lines. Spectrofluorometry was used to determine intra- and extracellular protein expression levels in terms of fluorescence, and the results were further confirmed by SDS-PAGE. The highest secretion efficiency was found for human IFNα2 signal peptide, achieving up to 2-fold increase in the amount of secreted protein compared to other signal peptides. The results showed that the combination of CMV promoter and IFNα2 signal peptide resulted highly efficient for recombinant protein production in HEK293 cells.
Copyright © 2016 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  HEK293 cells; Interferon-α2; Promoter; Protein expression; Signal peptide

Mesh:

Substances:

Year:  2016        PMID: 27725209     DOI: 10.1016/j.jbiotec.2016.10.005

Source DB:  PubMed          Journal:  J Biotechnol        ISSN: 0168-1656            Impact factor:   3.307


  7 in total

1.  Designing a novel E2-IFN-γ fusion protein against CSFV by immunoinformatics and structural vaccinology approaches.

Authors:  Yanmin Zhang; Weijian Zhang; Jun Cheng; Xuping Liu; Shiwei Miao; Wen-Song Tan; Liang Zhao
Journal:  Appl Microbiol Biotechnol       Date:  2022-05-07       Impact factor: 4.813

2.  Impact of different promoters, promoter mutation, and an enhancer on recombinant protein expression in CHO cells.

Authors:  Wen Wang; Yan-Long Jia; Yi-Chun Li; Chang-Qin Jing; Xiao Guo; Xue-Fang Shang; Chun-Peng Zhao; Tian-Yun Wang
Journal:  Sci Rep       Date:  2017-09-05       Impact factor: 4.379

3.  Synthesis and Comparative Evaluation of Novel Cationic Amphiphile C12-Man-Q as an Efficient DNA Delivery Agent In Vitro.

Authors:  Gunita Apsite; Irena Timofejeva; Aleksandra Vezane; Brigita Vigante; Martins Rucins; Arkadij Sobolev; Mara Plotniece; Karlis Pajuste; Tatjana Kozlovska; Aiva Plotniece
Journal:  Molecules       Date:  2018-06-26       Impact factor: 4.411

4.  Homogeneous antibody-drug conjugates: DAR 2 anti-HER2 obtained by conjugation on isolated light chain followed by mAb assembly.

Authors:  Mercè Farràs; Joan Miret; Marc Camps; Ramón Román; Óscar Martínez; Xavier Pujol; Stéphane Erb; Anthony Ehkirch; Sarah Cianferani; Antoni Casablancas; Jordi Joan Cairó
Journal:  MAbs       Date:  2020 Jan-Dec       Impact factor: 5.857

5.  Cerebral dopamine neurotrophic factor reduces α-synuclein aggregation and propagation and alleviates behavioral alterations in vivo.

Authors:  Katrina Albert; Diana P Raymundo; Anne Panhelainen; Ave Eesmaa; Liana Shvachiy; Gabriela R Araújo; Piotr Chmielarz; Xu Yan; Aastha Singh; Yraima Cordeiro; Fernando L Palhano; Debora Foguel; Kelvin C Luk; Andrii Domanskyi; Merja H Voutilainen; Henri J Huttunen; Tiago F Outeiro; Mart Saarma; Marcius S Almeida; Mikko Airavaara
Journal:  Mol Ther       Date:  2021-05-01       Impact factor: 12.910

6.  Heavy chain dimers stabilized by disulfide bonds are required to promote in vitro assembly of trastuzumab.

Authors:  Mercè Farràs; Ramón Román; Marc Camps; Joan Miret; Óscar Martínez; Xavier Pujol; Antoni Casablancas; Jordi Joan Cairó
Journal:  BMC Mol Cell Biol       Date:  2020-01-21

7.  In silico high throughput mutagenesis and screening of signal peptides to mitigate N-terminal heterogeneity of recombinant monoclonal antibodies.

Authors:  Xin Yu; Merlinda Conyne; Marc R Lake; Karl A Walter; Jing Min
Journal:  MAbs       Date:  2022 Jan-Dec       Impact factor: 5.857

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.